Atrium completes the sale of its Active Ingredients and Specialty Chemicals division

27-May-2008

In accordance with the terms previously announced, Atrium Innovations Inc. announced that it has completed the sale of its Active Ingredients and Specialty chemicals division for total proceeds of US$166.4 million in cash, subject to a post-closing working capital adjustment. Atrium is now a health and nutrition pure-play and the net proceeds from the transaction shall provide the Company with better financial flexibility to pursue its corporate strategy.

Other news from the department business & finance

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance